Search Results - "SMIT, W. M"

Refine Results
  1. 1
  2. 2

    Coping with somatic illnesses in online support groups: Do the feared disadvantages actually occur? by van Uden-Kraan, C.F., Drossaert, C.H.C., Taal, E., Lebrun, C.E.I., Drossaers-Bakker, K.W., Smit, W.M., Seydel, E.R., van de Laar, M.A.F.J.

    Published in Computers in human behavior (01-03-2008)
    “…People in stressful circumstances, such as serious health conditions, often turn to support groups. With the increase in the availability and popularity of the…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Efficacy of high-dose alkylating chemotherapy in HER2/neu-negative breast cancer by Rodenhuis, S., Bontenbal, M., van Hoesel, Q.G.C.M., Smit, W.M., Nooij, M.A., Voest, E.E., van der Wall, E., Hupperets, P., van Tinteren, H., Peterse, J.L., van de Vijver, M.J., de Vries, E.G.E.

    Published in Annals of oncology (01-04-2006)
    “…Background: High-dose chemotherapy in the adjuvant treatment of breast cancer has been abandoned by many. Patients and methods: 885 patients with stage III…”
    Get full text
    Journal Article
  5. 5

    Molecular subtypes of breast cancer and amplification of topoisomerase IIα : predictive role in dose intensive adjuvant chemotherapy by HANNEMANN, J, KRISTEL, P, DE VRIES, E. G. E, RODENHUIS, S, VAN DE VIJVER, M. J, VAN TINTEREN, H, BONTENBAL, M, VAN HOESEL, Q. G. C. M, SMIT, W. M, NOOIJ, M. A, VOEST, E. E, VAN DER WALL, E, HUPPERETS, P

    Published in British journal of cancer (20-11-2006)
    “…Benefit from chemotherapy treatment in breast cancer patients is determined by the molecular make-up of the tumour. In a retrospective analysis, we determined…”
    Get full text
    Journal Article
  6. 6

    Using 18th century storm-surge data from the Dutch Coast to improve the confidence in flood-risk estimates by Baart, F., Bakker, M. A. J., van Dongeren, A., den Heijer, C., van Heteren, S., Smit, M. W. J., van Koningsveld, M., Pool, A.

    Published in Natural hazards and earth system sciences (01-10-2011)
    “…For the design of cost-effective coastal defence a precise estimate is needed of the 1/10 000 per year storm surge. A more precise estimate requires more…”
    Get full text
    Journal Article
  7. 7

    Generation of B-cell chronic lymphocytic leukemia (B-CLL)-reactive T-cell lines and clones from HLA class I-matched donors using modified B-CLL cells as stimulators: implications for adoptive immunotherapy by HOOGENDOORN, M, WOLBERS, J. Olde, SMIT, W. M, SCHAAFSMA, M. R, BARGE, R. M. Y, WILLEMZE, R, FALKENBURG, J. H. F

    Published in Leukemia (01-07-2004)
    “…Allogeneic stem cell transplantation following reduced-intensity conditioning is being evaluated in patients with advanced B-cell chronic lymphocytic leukemia…”
    Get full text
    Journal Article
  8. 8

    A phase II trial of ZD0473 in platinum-pretreated ovarian cancer by Gore, M.E., Atkinson, R.J., Thomas, H., Cure, H., Rischin, D., Beale, P., Bougnoux, P., Dirix, L., Smit, W.M.

    Published in European journal of cancer (1990) (01-12-2002)
    “…The primary aim of this phase II trial was to assess the antitumour activity of ZD0473 in ovarian cancer patients who had failed initial platinum-based…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Relationship between elevated creatine phosphokinase and the clinical spectrum of rhabdomyolysis by Veenstra, J, Smit, W M, Krediet, R T, Arisz, L

    “…The incidence, causes and complications of severe rhabdomyolysis (creatine phosphokinase (CK) > or = 5000 U/l) were studied during a 7-year study period in a…”
    Get more information
    Journal Article
  11. 11
  12. 12

    Capecitabine, epirubicin and cisplatin in the treatment of oesophagogastric adenocarcinoma by CORPORAAL, S, SMIT, W. M, RUSSEL, M. G. V. M, VAN DER PALEN, J, BOOT, H, LEGDEUR, M. C. J. C

    Published in Netherlands journal of medicine (01-05-2006)
    “…Inoperable or metastatic oesophagogastric adenocarcinoma has a poor prognosis. From the many different chemotherapeutic regimens used in the past, a…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Generation of leukemia-reactive cytotoxic T lymphocytes from HLA-identical donors of patients with chronic myeloid leukemia using modifications of a limiting dilution assay by SMIT, W. M, RIJNBEEK, M, VAN BERGEN, C. A. M, WILLEMZE, R, FALKENBURG, J. H. F

    Published in Bone marrow transplantation (Basingstoke) (01-03-1998)
    “…Donor leukocyte transfusions (DLT) have an anti-leukemic effect in most patients with a relapse of chronic myeloid leukemia (CML) after allogeneic stem cell…”
    Get full text
    Journal Article
  15. 15

    Phase I and pharmacological trial of lapatinib in combination with gemcitabine in patients with advanced breast cancer by van der Noll, R., Smit, W. M., Wymenga, A. N. M., Boss, D. S., Grob, M., Huitema, A. D. R., Rosing, H., Tibben, M. M., Keessen, M., Rehorst, H., Beijnen, J. H., Schellens, J. H. M.

    Published in Investigational new drugs (01-12-2015)
    “…Summary Background Lapatinib has proven efficacy as monotherapy and in combination with capecitabine in patients with metastatic breast cancer (MBC)…”
    Get full text
    Journal Article
  16. 16

    Role of morphological variability in the evolution of nearshore sandbars by Smit, M.W.J., Reniers, A.J.H.M., Stive, M.J.F.

    Published in Coastal engineering (Amsterdam) (01-11-2012)
    “…Computations using a depth-averaged morphological process-based model of a double nearshore bar system have been used to test the hypothesis that bathymetries…”
    Get full text
    Journal Article
  17. 17

    The morphological response of a nearshore double sandbar system to constant wave forcing by Smit, M.W.J., Reniers, A.J.H.M., Ruessink, B.G., Roelvink, J.A.

    Published in Coastal engineering (Amsterdam) (01-10-2008)
    “…Results of 2DH morphodynamic computations are presented to quantify the temporal evolution of the crescentic patterns emerging in a double nearshore bar system…”
    Get full text
    Journal Article
  18. 18

    Results of ZD0473 in platinum-pretreated ovarian cancer: analysis according to platinum free interval by Gore, M.E., Atkinson, R.J., Thomas, H., Cure, H., Rischin, D., Beale, P., Bougnoux, P., Dirix, L., Smit, W.M.

    Published in European journal of cancer (1990) (01-12-2002)
    “…Resistance to platinum-containing regimens can develop in many women with ovarian cancer and may lead to relapse in > 80% of patients. ZD0473 is a…”
    Get full text
    Journal Article
  19. 19
  20. 20